Clinical use of azelnidipine in the treatment of hypertension in Chinese patients

References

• LiuLSWriting Group of 2010 Chinese Guidelines for the Management of Hypertension2010 Chinese guidelines for the management of hypertensionZhonghua Xin Xue Guan Bing Za Zhi2011397579615 Chinese22088239
   PubMedGoogle Scholar
• RedonJManciaGSleightPSafety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)J Am Coll Cardiol2012591748322192672
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983519118175517629635947
   PubMed Web of Science ®Google Scholar
• MesserliFHManciaGContiCRDogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?Ann Intern Med20061441288489316785477
   PubMed Web of Science ®Google Scholar
• SarnakMJGreeneTWangXThe effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease studyAnn Intern Med2005142534235115738453
   PubMed Web of Science ®Google Scholar
• AppelLJWrightJJGreeneTIntensive blood-pressure control in hypertensive chronic kidney diseaseN Engl J Med20103631091892920818902
   PubMed Web of Science ®Google Scholar
• UpadhyayAEarleyAHaynesSMUhligKSystematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifierAnn Intern Med2011154854154821403055
   PubMed Web of Science ®Google Scholar
• No authors listedAzelnidipine. CS 905, Calblock, RS 9054Drugs R D20034212212512718569
   PubMedGoogle Scholar
• KawabataKUrasakiYSimultaneous determination of azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci200684414552
   PubMed Web of Science ®Google Scholar
• KawabataKSamataNUrasakiYEnantioselective determination of azelnidipine in human plasma using liquid chromatography-tandem mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20078521–2389397
   PubMed Web of Science ®Google Scholar
• CatterallWAPerez-ReyesESnutchTPStriessnigJInternational Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channelsPharmacol Rev200557441142516382099
   PubMed Web of Science ®Google Scholar
• NakanoKEgashiraKTadaHA third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primatesJ Hypertens20062491881188916915039
   PubMed Web of Science ®Google Scholar
• OizumiKNishinoHKoikeHSadaTMiyamotoMKimuraTAntihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blockerJpn J Pharmacol198951157642810942
   PubMedGoogle Scholar
• NakamuraTSugayaTKawagoeYAzelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney diseaseAm J Med Sci2007333632132617570983
   PubMedGoogle Scholar
• YamagishiTEfficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipineHypertens Res2006291076777317283863
   PubMedGoogle Scholar
• KarioKSatoYShirayamaMInhibitory effects of azelnidipine tablets on morning hypertensionDrugs R D2013131637323512719
   PubMedGoogle Scholar
• WellingtonKScottLJAzelnidipineDrugs200363232613262414636080
   PubMedGoogle Scholar
• LiLDingLMaPCStudy on Pharmacokinetics of Azelnidipine in Healthy VolunteersZhongguo Yao Xue Za Zhi2008431310081011 Chinese
   Google Scholar
• ZouJJJiHJZhouXHDetermination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteersPharmazie200863856857018771003
   PubMed Web of Science ®Google Scholar
• LiangYGGaoHZHuJCLiuZYPharmacokinetics of azelnidipine in healthy volunteersZhongguo Lin Chuang Yao Li Xue Za Zhi2008244323325 Chinese
   Google Scholar
• ZhongSJShiAMHuaWYHuanMZhangQYPharmacokinetic Study of Azelnidipine Tablets in Healthy VolunteersZhongguo Yao Fang2011221816721674 Chinese
   Google Scholar
• ChenYLinYLiJStudy on Pharmacokinetics of Azelnidipine Tablets in Chinese Healthy VolunteersZhongguo Yao Fang2011223835853588 Chinese
   Google Scholar
• ShentuJFuLZhouHDetermination of amlodipine in human plasma using automated online solid-phase extraction HPLC-tandem mass spectrometry: application to a bioequivalence study of Chinese volunteersJ Pharm Biomed Anal20127061461822770846
   PubMed Web of Science ®Google Scholar
• ShuCRWeiLLGeMMStudy on Pharmacokinetics of Azelnidipine Tablet in Healthy VolunteersZhongguo Yao Fang20122310896898 Chinese
   Google Scholar
• LiHLiXHEvaluation of Therapeutic Efficacy of Azelnidipine for Essential Hypertension in the Youth by Ambulatory Blood Pressure MonitoringZhongguo Yao Fang20132436116117 Chinese
   Google Scholar
• QiBHEffect of Azelnidipine on high blood pressure complicated with tachycardiaHainan Yi Xue Yuan Xue Bao2010166716717 Chinese
   Google Scholar
• PengLZhaoXSMaZZhangHYThe influence of amlodipine and azelnidipine on serum levels of hs-CRP and TIMP-1 of hypertensive patientsBeijing Yi Xue2009318461464 Chinese
   Google Scholar
• ZhaoXWuFJiaSAzelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patientsClin Exp Hypertens201032637237621029001
   PubMed Web of Science ®Google Scholar
• WenYPClinical Observation of Azelnidipine on Mild to Moderate HypertensionGuangxi Yi Xue20113312326 Chinese
   Google Scholar
• ZhengJLEffects of azelnidipine and amlodipine on mid-to-moderate essential hypertension in the older with dynamic blood pressureHebei Yi Yao2011332030923094 Chinese
   Google Scholar
• ZhangHPengLZhaoXSAntihyPertensive comparison of amlodipine and azelnidipine for mild to moderate essential hypertensionZhongguo Xin Xue Guan Za Zhi2011164277279 Chinese
   Google Scholar
• WenYPHuangRJEffects of azelnidipine and zofenopril on ambulatory blood pressure in patients with hypertensionGuangxi Yi Xue2011331012911293 Chinese
   Google Scholar
• JiaoHXZhangMQZhaoJYChenXSEvaluation on curative effect of azelnidipine on hypertension and its inhibitory effect on atherosclerosisJilin Da Xue Xue Bao (Yi Xue Ban)2012384736740 Chinese
   Google Scholar
• HuangRJZhengYXHeMLEffects of azelnidipine and amlodipine on artery stiffness and dynamic pulse pressure in patients with essential hypertensionShi Yong Yi Xue Za Zhi2012281525882590 Chinese
   Google Scholar
• ZhaoKStudy on effect of azelnidipine plus atorvastatin in hypertension patients with coronary artery diseaseHai Xia Yao Xue20122411146147 Chinese
   Google Scholar
• LiDDDongWChenYDAzelnidipine in treatment of mild-moderate essential hypertension: A clinical trialJie Fang Jun Yi Xue Yuan Xue Bao2013349977980 Chinese
   Google Scholar
• LiYYChenWSYuFEvaluating azelnidipine and amlodipine treatment in mild-to-moderate primary hypertension with ambulatory blood pressure monitoring systemLin Chuang He Li Yong Yao Za Zhi201366116117 Chinese
   Google Scholar
• YiSXWuZZShaoNWangYBFengWFThe influence of azelnidipine on left ventricular diastolic function in hypertensive patientsXian Dai Zhong Xi Yi Jie He Za Zhi2013222527972798 Chinese
   Google Scholar
• HuangRJZhengYXHeMLEffects of Azelnidipine and amlodipine on circadian rhythm of blood pressure and atherosclerosis in patients with mild-to-moderate essential hypertensionGuangxi Yi Ke Da Xue Xue Bao201431018992 Chinese
   Google Scholar
• WangJKangDHongQHealth-related quality of life in hypertensive patientsZhonghua Yi Xue Za Zhi1999798599602 Chinese11715408
   PubMedGoogle Scholar
• LiWLiuLPuenteJGHypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in ChinaJ Hypertens20052391667167616093911
   PubMed Web of Science ®Google Scholar
• ChenYWangSYChiGBYuXHHongCLiAREvaluation of quality of life of hypertensive patientsDi Yi Jun Yi Da Xue Xue Bao2005251113871389 Chinese16305962
   PubMedGoogle Scholar
• WangRZhaoYHeXImpact of hypertension on health-related quality of life in a population-based study in Shanghai, ChinaPublic Health2009123853453919665154
   PubMed Web of Science ®Google Scholar
• QianYZhangJLinYA tailored target intervention on influence factors of quality of life in Chinese patients with hypertensionClin Exp Hypertens2009311718219172461
   PubMed Web of Science ®Google Scholar
• LawrenceWFFrybackDGMartinPAKleinRKleinBEHealth status and hypertension: a population-based studyJ Clin Epidemiol19964911123912458892491
   PubMed Web of Science ®Google Scholar
• MaCChenSZhouYHuangCTreatment adherence of Chinese patients with hypertension: a longitudinal studyAppl Nurs Res201326422523124050917
   PubMed Web of Science ®Google Scholar
• YangGQMedication adherence and its associated factors in patients with essential hypertensionZhongguo Yi Yao Zhi Nan2009774041 Chinese
   Google Scholar
• CaoZXXingAJLiuYQShiJHWuSLFactors associated with antihypertensive drug compliance in patients with essential hypertensionZhonghua Gao Xue Ya Za Zhi2009179843844 Chinese
   Google Scholar
• RenHShengXCZhangHLuoHPXuJFuHA study on relationship between compliance with anti-hypertension therapy and assessment of quality of health care in patients with hypertension in communityZhonghua Yu Fang Yi Xue Za Zhi2014485345349 Chinese24985370
   PubMedGoogle Scholar
• WongMCJiangJYGriffithsSMFactors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort studyJ Epidemiol Community Health2010641089590120693495
   PubMed Web of Science ®Google Scholar
• WongMCJiangJYGibbsTGriffithsSMFactors associated with antihypertensive drug discontinuation among Chinese patients: a cohort studyAm J Hypertens200922780281019360004
   PubMed Web of Science ®Google Scholar
• LeeGKWangHHLiuKQCheungYMoriskyDEWongMCDeterminants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence ScalePLoS One201384e6277523638143
   PubMed Web of Science ®Google Scholar
• WangWYanFXueCYZhangXLiZHFactors Influencing Patients’ Compliance with Hypertension Management in the Community: Qualitative Research SynthesisZhongguo Xun Zheng Yi Xue Za Zhi2010104429432 Chinese
   Google Scholar
• WangWLauYLooAChowAThompsonDRMedication adherence and its associated factors among Chinese community-dwelling older adults with hypertensionHeart Lung201443427828324856232
   PubMed Web of Science ®Google Scholar